Are cannabidiol (CBD) levels in consumer food products well tested?-A review

被引:0
|
作者
Siddiqui, Shahida Anusha [1 ,2 ,9 ]
Fidan, Hafize [3 ]
Stankov, Stanko [3 ]
Mehdizadeh, Mohammad [4 ]
Ambartsumov, Tigran Garrievich [5 ]
Kharazmi, Mohammad [6 ]
Singh, Shubhra [7 ]
Jafari, Seid Mahdi [8 ]
机构
[1] Tech Univ Munich, Campus Straubing Biotechnol & Sustainabil, Straubing, Germany
[2] German Inst Food Technol DIL eV, D Quakenbruck, Germany
[3] Univ Food Technol, Fac Econ, Dept Tourism & Culinary Management, Plovdiv, Bulgaria
[4] Univ Mohaghegh Ardabili, Fac Agr & Nat Resources, Dept Agron & Plant Breeding, Ardebil, Iran
[5] ITMO Univ, Fac Technol & Innovat Management, St Petersburg, Russia
[6] Univ Calif Riverside, Fac Med, Riverside, CA USA
[7] Natl Pingtung Univ Sci & Technol, Dept Trop Agr & Int Cooperat, Pingtung City, Taiwan
[8] Gorgan Univ Agr Sci & Nat Resources, Dept Food Mat & Proc Design Engn, Gorgan, Iran
[9] Tech Univ Munich TUM, Campus Straubing Biotechnol & Sustainabil, Essigberg 3, D-94315 Straubing, Germany
来源
FOOD FRONTIERS | 2023年 / 4卷 / 04期
关键词
cannabidiol; Cannabis sativa L; CBD; consumers; edibles; phytocannabinoids; properties; LUNG-CANCER; DOUBLE-BLIND; SATIVA L; POOLED ANALYSIS; MARIJUANA USE; HEMP SEED; CANNABINOIDS; ANXIETY; RISK; COMBINATION;
D O I
10.1002/fft2.308
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
There are differing views on cannabis and phytocannabinoid usage in diverse domains of application. This review explores the advantages and drawbacks of using cannabis and phytocannabinoids, including their effects on human health, in addition to highlighting the need for precise and repeatable analytical methods for quantifying controlled phytocannabinoids in consumer cannabidiol (CBD) products and foods. The composition and characteristics of the phytochemicals found in cannabis, the advantages and disadvantages of controlled and uncontrolled phytocannabinoids, and the need for regulation and standardization in the use of cannabis and products containing phytocannabinoids are all covered in this review of the pertinent literature. Cannabinoids used illegally can have negative consequences, but controlled phytocannabinoids found in consumer CBD products are relatively safe and unlikely to cause any adverse effects. It is necessary to restrict the amount of CBD in foods and consumer products in order to ensure safety. To measure the amount of restricted phytocannabinoids in these products, accurate analytical techniques are also required. In order to increase the use of cannabis among consumers, more research is needed to improve our understanding of the bioavailability and metabolic pathways of these compounds. Furthermore, consumers want clear and uniform federal rules governing the amount of CBD in food products in order to ensure correct dosing. To promote safe and responsible use, cannabis and phytocannabinoids must be carefully considered, regulated, and standardized. It is necessary for consumers to have clear, consistent standards governing the percentage of CBD in their food products. As a result, they would know the exact amount of CBD in their products.
引用
收藏
页码:1778 / 1793
页数:16
相关论文
共 50 条
  • [1] What drives consumer perceptions and adoption of cannabidiol (CBD) products?
    Choi, Laee
    Hwang, Jiyoung
    [J]. JOURNAL OF MARKETING MANAGEMENT, 2023, 39 (15-16) : 1417 - 1450
  • [2] Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners
    Miller, Owen S.
    Elder, Edmund J., Jr.
    Jones, Karen J.
    Gidal, Barry E.
    [J]. EPILEPSY & BEHAVIOR, 2022, 127
  • [3] Review of the oral toxicity of cannabidiol (CBD)
    Gingrich, Jeremy
    Choudhuri, Supratim
    Cournoyer, Patrick
    Downey, Jason
    Jacobs, Kristi Muldoon
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2023, 176
  • [4] Cannabidiol (CBD) and Insomnia : Literature review
    Higueras, T. Gutierrez
    Cortes, F. Calera
    Lopez, E. D. Servin
    Arjona, L. Montes
    Alonso, S. Sainz De La Cuesta
    Fores, S. Vicent
    [J]. EUROPEAN PSYCHIATRY, 2022, 65 : S809 - S809
  • [5] Unexpected toxicity of cannabidiol (CBD) oil health products
    Van Den Hengel-Koot, Irma S.
    Nugteren-Van Lonkhuyzen, Johanna J.
    Hondebrink, Laura
    Rietjens, Saskia J.
    De Vries, Irma
    Van Riel, Antoinette J. H. P.
    [J]. CLINICAL TOXICOLOGY, 2018, 56 (06) : 516 - 516
  • [6] Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
    Heider, Camren G.
    Itenberg, Sasha A.
    Rao, Jiajia
    Ma, Hang
    Wu, Xian
    [J]. BIOLOGY-BASEL, 2022, 11 (06):
  • [7] Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies
    Silmore, Lucy H.
    Willmer, Andrew R.
    Capparelli, Edmund V.
    Rosania, Gus R.
    [J]. PHARMACOTHERAPY, 2021, 41 (04): : 405 - 420
  • [8] Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms
    Moore, Andrew
    Straube, Sebastian
    Fisher, Emma
    Eccleston, Christopher
    [J]. JOURNAL OF PAIN, 2024, 25 (04): : 833 - 842
  • [9] Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
    Leas, Eric C.
    Moy, Natalie
    McMenamin, Sara B.
    Shi, Yuyan
    Benmarhnia, Tarik
    Stone, Matthew D.
    Trinidad, Dennis R.
    White, Martha
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (13)
  • [10] Data gaps in the risk assessment of Cannabidiol (CBD) as a Novel Food
    Rossi, A.
    Albert, O.
    Kouloura, E.
    Laganaro, M.
    Gonzalez, A. Munoz
    Fernandez, E. Noriega
    Garciarena, I. Nuin
    Rivero Pino, F.
    Zakidou, P.
    Ververis, E.
    Germini, A.
    Kass, G. E. N.
    [J]. TOXICOLOGY LETTERS, 2023, 384 : S291 - S292